Relay Therapeutics, Inc. (RLAY)
19.47
-0.22
(-1.12%)
USD |
NASDAQ |
Oct 29, 16:00
19.29
-0.18
(-0.92%)
After-Hours: 05:26
Relay Therapeutics Total Return Level : 19.47 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 19.47 |
| October 28, 2026 | 19.69 |
| October 27, 2026 | 18.84 |
| October 26, 2026 | 18.12 |
| October 23, 2026 | 18.18 |
| October 22, 2026 | 18.34 |
| October 21, 2026 | 18.41 |
| October 20, 2026 | 18.45 |
| October 19, 2026 | 17.09 |
| October 16, 2026 | 16.28 |
| October 15, 2026 | 17.30 |
| October 14, 2026 | 17.06 |
| October 13, 2026 | 17.36 |
| October 12, 2026 | 17.98 |
| October 09, 2026 | 17.88 |
| October 08, 2026 | 17.41 |
| October 07, 2026 | 17.95 |
| October 06, 2026 | 18.74 |
| October 05, 2026 | 19.39 |
| October 02, 2026 | 18.96 |
| October 01, 2026 | 18.49 |
| September 30, 2026 | 18.05 |
| September 29, 2026 | 18.36 |
| September 28, 2026 | 17.69 |
| September 25, 2026 | 17.47 |
| Date | Value |
|---|---|
| September 24, 2026 | 17.73 |
| September 23, 2026 | 18.03 |
| September 22, 2026 | 19.35 |
| September 21, 2026 | 18.19 |
| September 18, 2026 | 18.84 |
| September 17, 2026 | 19.19 |
| September 16, 2026 | 18.84 |
| September 15, 2026 | 18.97 |
| September 14, 2026 | 19.06 |
| September 11, 2026 | 18.87 |
| September 10, 2026 | 18.89 |
| September 09, 2026 | 18.66 |
| September 08, 2026 | 19.11 |
| September 04, 2026 | 19.04 |
| September 03, 2026 | 19.01 |
| September 02, 2026 | 18.51 |
| September 01, 2026 | 18.49 |
| August 31, 2026 | 18.38 |
| August 28, 2026 | 18.77 |
| August 27, 2026 | 19.42 |
| August 26, 2026 | 19.46 |
| August 25, 2026 | 20.57 |
| August 24, 2026 | 19.76 |
| August 21, 2026 | 19.44 |
| August 20, 2026 | 19.70 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| SELLAS Life Sciences Group, Inc. | 10.16 |
| TG Therapeutics, Inc. | 58.08 |
| Karyopharm Therapeutics, Inc. | 0.8798 |
| Spyre Therapeutics, Inc. | 98.96 |
| Akebia Therapeutics, Inc. | 0.7422 |